Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities.

Authors:
Pardee AD; Butterfield LH.

Journal:
Oncoimmunology

Publication Year: 2012

DOI:
10.4161/onci.1.1.18344

PMCID:
PMC3376967

PMID:
22720211

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Oncoimmunology

Abbreviation: Oncoimmunology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor ac…
Albu DI; Wolf BJ; Qin Y and 12 more (2024) - Transparency Score: 2/6
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherap…
Ying L; Hu Z; Lu Y and 11 more (2024) - Transparency Score: 2/6
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ; Martinenaite E; Landkildehus Lisle T and 5 more (2024) - Transparency Score: 3/6
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8<sup>+</sup>T cell func…
Wei W; Tian L; Zheng X and 6 more (2024) - Transparency Score: 3/6
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor …
Ramil CP; Xiang H; Zhang P and 10 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of Potential Conflicts of Interest ADP: none to declare. LHB is co-inventor of patents covering aspects of AFP as a target for T cell-mediated anti-HCC immunity."

Evidence found in paper:

"This study was supported by research funding from the University of Pittsburgh Cancer Institute, NCI RO1 CA 138635 (LHB), and was supported in part by the UPCI CCSG award P30CA047904."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025